Dallas, United States
Texas Oncology is a pioneering healthcare startup that has been leading the way in high-quality, community-based cancer care since its establishment in 1986. With over 530 physicians and 280 locations spanning across Texas and southeastern Oklahoma, the company offers a unique approach to oncology care, allowing patients to access cutting-edge treatments while remaining close to their support network. Additionally, Texas Oncology provides opportunities for patients to participate in nationally recognized clinical trials for various cancers, further enhancing its reputation as an industry leader.
Specializing in the biotechnology and healthcare sectors, Texas Oncology plays a significant role in US Oncology Research and has contributed to the development of nearly 100 FDA-approved cancer-fighting drugs, representing approximately one-third of all approved cancer therapies in the United States.
While specific details about its headquarters and recent investments are not provided, Texas Oncology's track record of innovation, research, and impact in the field of oncology positions it as a compelling investment opportunity for venture capitalists seeking to support companies at the forefront of cancer treatment and research.
